These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Retained and discontinued conventional and unconventional measures by patients with Bechterew disease for modifying the course of illness]. Falkenbach A; Toennemann J; Mur E Z Rheumatol; 2002 Jun; 61(3):271-8. PubMed ID: 12219631 [TBL] [Abstract][Full Text] [Related]
3. [Medicomechanic therapy of Strumpell-Bechterew-Pierre-Marie disease]. ARNOLD A Arch Phys Ther (Leipz); 1952; 4(5):360-5. PubMed ID: 12997066 [No Abstract] [Full Text] [Related]
4. [On the so-called Bechterew disease (ankylosing spondylitis), a chronic inflammatory spinal disease]. Rave O Krankenpfl J; 1988 Jun; 26(6):252-5. PubMed ID: 3398467 [No Abstract] [Full Text] [Related]
5. [Boomerang. On the book "Alternative Medicine", 5th edition]. Federspiel K Versicherungsmedizin; 2006 Mar; 58(1):39. PubMed ID: 16553229 [No Abstract] [Full Text] [Related]
6. [Therapy of morbus Bechterew]. RUTT A Dtsch Med Wochenschr; 1952 May; 77(20):649-52. PubMed ID: 14954766 [No Abstract] [Full Text] [Related]
7. [Treatment and follow up care of Bechterew patients]. Röhlig H; Laschner W; Schüler KH Beitr Orthop Traumatol; 1968; 15(12):715-8. PubMed ID: 4308197 [No Abstract] [Full Text] [Related]
8. [Expert assessment of patients with seronegative spondyloarthropathies]. Kellner H Z Rheumatol; 2002 Dec; 61(6):643-51. PubMed ID: 12491127 [TBL] [Abstract][Full Text] [Related]
9. [Proof of efficacy as basis for assessment of diagnostic and therapeutic methods in medical expert testimony]. Wehner M Versicherungsmedizin; 2002 Dec; 54(4):182-4. PubMed ID: 12625362 [No Abstract] [Full Text] [Related]
11. [On the prescription of injection preparations Iscador and Helixor]. Holmberg K Lakartidningen; 2000 Sep; 97(38):4182, 4185. PubMed ID: 11068394 [No Abstract] [Full Text] [Related]
12. [Not only ineffective, but also potentially dangerous. Therapy with "universal specific remedies"]. Hakimi R MMW Fortschr Med; 2002 Dec; 144(50):49-51. PubMed ID: 14610866 [No Abstract] [Full Text] [Related]
13. [Change in legal assessment of unconventional medical methods in federal health insurance--consequences for social medicine expert assessment]. Nüchtern E Gesundheitswesen; 1998; 60(8-9):467-72. PubMed ID: 9816763 [TBL] [Abstract][Full Text] [Related]
14. [Association of ankylosing spondylitis (Bechterew disease) and the HLA system]. Wegener S; Mach J Z Arztl Fortbild (Jena); 1980 Oct; 74(19):895-8. PubMed ID: 7467460 [No Abstract] [Full Text] [Related]
15. [Effect of a positive family history on the prognosis in patient with Bechterew disease]. Falkenbach A; Griessmayer H; Tripathi R Wien Klin Wochenschr; 1998 Jan; 110(1):20-2. PubMed ID: 9499474 [TBL] [Abstract][Full Text] [Related]
16. [Ankylosing spondylitis (Bechterew) and tissue antigen HLA-B27. III, Heredity of ankylosing spondylitis (Bechterew)]. Gerber N; von Felten A; Böni A; Wagenhäuser F Z Rheumatol; 1977; 36(7-8):230-8. PubMed ID: 919798 [TBL] [Abstract][Full Text] [Related]
17. [Expert assessment of naturopathy, alternative treatment methods and homeopathic practitioners]. Ostendorf GM Versicherungsmedizin; 1994 Oct; 46(5):174-7. PubMed ID: 7974991 [TBL] [Abstract][Full Text] [Related]
18. [Special treatment methods in general practice--legal medicine viewpoint]. Wagner HJ Z Arztl Fortbild (Jena); 1996 Apr; 90(2):123-5. PubMed ID: 8686335 [TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of ankylosing spondylitis according to FML]. Schoger GA Verh Dtsch Ges Rheumatol; 1969; 1():215-9. PubMed ID: 5403954 [No Abstract] [Full Text] [Related]